OPERATIONS OF BRACHYTHERAPY FOR PROSTATE CANCER WITH THE USE OF LOW-DOSE-RATE MICROSOURCES WERE HELD AT I.M. SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY (1ST MSMU)
Three operations on prostate cancer treatment by low-dose-rate brachytherapy were performed at the Clinical Center of the First MSMU, the Office of Information Policy and Public Relations of the University reports.
The operations were carried out by doctors of Fronshteyn Urology Clinic: Senior researcher at the Research Institute of “Uronephrology” Ph.D. Enikeev D.V. and Assistant to Department of Urology, MD Chinenov D.V. in the framework of high-tech medical care provision to citizens of the Russian Federation.
According to official statistics of the Association of oncologists of Russia, more than 36,493 people were registered with primary diagnosis of prostate cancer in Russia in 2014. More than 7,500 of them are potential patients for prostate brachytherapy operation.
"Carrying out of such operations in our clinic is a good opportunity to provide patients of the First MSMU with one of the efficient treatment options for prostate cancer,"- said Deputy Director of Urology Clinic Prof. MD Rapoport L.M..
"In 2016, we plan to perform 25 brachytherapy operations for prostate cancer. In our clinic not only residents of Moscow will be able to be treated by this method, but also all the citizens of Russia ", - he said. According to Director General of Bebig Company producing microsources for low-dose-rate brachytherapy, Kirill Mayorov, brachytherapy is a widely spread and very efficient low-traumatic method of cancer treatment in the world. "Brachytherapy is a highly effective method of prostate cancer treatment, in 98% of cases, completely destroying the malignant disease.
The main components of the operation are radiation microsources implanted along the perimeter of the tumor,"- he explained. The low-dose-rate brachytherapy has been used in Europe and America for over 30 years. In Russia, the low-dose brachytherapy is registered in the list of high-tech medical care, financed by the state under the program of state guarantees of free medical care.
At the present moment the treatment of prostate cancer by this method is carried out at 27 state medical centers.
